Robert Richmond
Director, Payer Access & Reimbursement at Gamida Cell Ltd.- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Gamida Cell Ltd.
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Director, Payer Access & Reimbursement
-
Sep 2021 - Present
-
-
-
PharmaEssentia
-
Taiwan
-
Biotechnology Research
-
100 - 200 Employee
-
Senior Director, Market Access
-
Sep 2020 - Mar 2021
• Downsized due to CRL. • Responsible for all aspects of the managed markets space including Market Access Payer Strategy. • Recruited and managed 4 Access Directors responsible for key payer/ PBM accounts. • Managed the GPO/ IOD/ SP channel strategy and set operational objectives. • In charge of and deliver market access tools such as AMCP dossier, PIE deck, BIM and Value deck. • Downsized due to CRL. • Responsible for all aspects of the managed markets space including Market Access Payer Strategy. • Recruited and managed 4 Access Directors responsible for key payer/ PBM accounts. • Managed the GPO/ IOD/ SP channel strategy and set operational objectives. • In charge of and deliver market access tools such as AMCP dossier, PIE deck, BIM and Value deck.
-
-
-
Stemline Therapeutics
-
United States
-
Biotechnology
-
200 - 300 Employee
-
National Director, Market Access & Reimbursement
-
Jun 2018 - Sep 2020
• Recruited, trained and led a high performing team of 5 Regional Account Directors. • Developed strategies and tactics across all aspects of Market Access. • Set objectives related to removing access barriers pertaining to pricing, coding, billing and reimbursement. Managed US distribution channels including 3PL and SDs. • Managed EU distribution model, EAPs in Italy and France and order to cash. • Assisted with community/ GPO strategy and Strategic Partner Initiatives. • Member of the Market Access Leadership Team. Show less
-
-
-
AMAG Pharmaceuticals
-
United States
-
Pharmaceutical Manufacturing
-
100 - 200 Employee
-
Strategic Account Manager- Hem/Onc Market Access
-
Jan 2016 - Jun 2018
• Present GPO contracts to large Hem/ Onc groups including Florida Cancer Specialists, Cancer Specialists of North FL, Alabama Oncology, Georgia Cancer Specialists and Clearview Cancer Institute. • Negotiate and implement contracted pricing for Feraheme (infusion for anemia) with large IDNs and Cancer Centers.(University of Miami, Moffitt, Florida Hospital, Shands UAB, Carolina Health System. . Provide all access solutions to Institutions and large community practices including reimbursement/ coding and HUB services. • Establish favorable formulary position with large regional payers and Medicare Administrative Contractors. • Launched new indication and named to the Product Advisory Team. • Ranked 1/6 nationally in 2016 and ranked 2/6 in Q2 2017. Show less
-
-
-
Dendreon
-
United States
-
Biotechnology Research
-
300 - 400 Employee
-
Institutional Account Executive
-
Oct 2012 - Jan 2016
• Drove sales of Provenge (immunotherapy for prostate cancer) in the largest academic hospitals and cancer centers. • Responsible for all clinical, operational and financial success of Provenge. • Awarded the Circle of Excellence Award in 2014. • Achieved a natinal ranking of 2/15 and reached 135% of goal in 2014. • Nominated to the Marketing Executive Council by sales leadership team in 2015 • Ranked 2/15 nationally in Q1 and grew 40% over baseline in Q2of 2015. • Drove sales of Provenge (immunotherapy for prostate cancer) in the largest academic hospitals and cancer centers. • Responsible for all clinical, operational and financial success of Provenge. • Awarded the Circle of Excellence Award in 2014. • Achieved a natinal ranking of 2/15 and reached 135% of goal in 2014. • Nominated to the Marketing Executive Council by sales leadership team in 2015 • Ranked 2/15 nationally in Q1 and grew 40% over baseline in Q2of 2015.
-
-
-
Abbott Molecular/Cynogen
-
Southeast
-
Regional Sales Manager
-
Nov 2007 - Oct 2012
• Recruited, trained, led, and motivated a team of 6-8 Oncology Sales Specialists responsible for promoting molecular laboratory services in the Southeast Region and Puerto Rico. • Directed the sales of FISH and ALK molecular testing at a startup molecular laboratory with a sales team calling on Oncologists, Pathologists, Urologists and Laboratory Directors. • Collaborated in all operational, strategic, and sales management decisions for the company. • Analyzed monthly metrics to identify opportunities for optimal market growth. • Coached team on selling techniques, account management strategy, hospital sales acumen, and product knowledge. • Cultivated team members to enhance individual skill sets and hone local market knowledge. • Partnered with marketing, management, and field sales to implement strategies to grow market share. • Conducted performance reviews, led team teleconferences, and developed strategic business plans. • Key Accomplishments: - Won President’s Club in 2009 and 2010 with the team achieving 111% and 108% of sales goals respectively. - Coached and developed 3 sales representatives to Senior Sales Specialist promotions. Show less
-
-
-
Abbott Molecular
-
Florida and Georgia
-
Molecular Physician Specialist
-
Feb 2004 - Nov 2007
• Marketed molecular tests for bladder and breast cancer to Urologists, Oncologists, and laboratories in FL and GA. • Key Accomplishments: - Won President’s Club Awards in 2005 and 2007. - Ranked 2/38 companywide in Abbott Molecular achieving 136% of quota in 2007. - Ranked 1/30 companywide in Abbott Molecular achieving 161% of quota growing territory 206% in 2005. • Marketed molecular tests for bladder and breast cancer to Urologists, Oncologists, and laboratories in FL and GA. • Key Accomplishments: - Won President’s Club Awards in 2005 and 2007. - Ranked 2/38 companywide in Abbott Molecular achieving 136% of quota in 2007. - Ranked 1/30 companywide in Abbott Molecular achieving 161% of quota growing territory 206% in 2005.
-
-
-
Allergan
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Botox Medical Consultant
-
Jan 2002 - Feb 2004
• Promoted Botox to academic institutions, stroke centers and neurologists. • Completed the year 2003 top 25% out of 90 in the company (109% of quota). • Completed the year 2002 112% of quota (35% incremental growth). • Promoted Botox to academic institutions, stroke centers and neurologists. • Completed the year 2003 top 25% out of 90 in the company (109% of quota). • Completed the year 2002 112% of quota (35% incremental growth).
-
-
-
Searle
-
Pharmaceutical Manufacturing
-
200 - 300 Employee
-
Medical Sales Representative
-
Nov 1997 - Jan 2002
• Promoted Celebrex, Daypro, and Ambien. • Ranked # 7 companywide for first quarter sales for Celebrex in 2001. • Completed the year 110% of quota for all products (Celebrex, Daypro, Ambien- 2000) • Achieved 132% of quota for Celebrex in 1999. • Completed the year ranked # 10 companywide for Daypro in 1998. • Promoted Celebrex, Daypro, and Ambien. • Ranked # 7 companywide for first quarter sales for Celebrex in 2001. • Completed the year 110% of quota for all products (Celebrex, Daypro, Ambien- 2000) • Achieved 132% of quota for Celebrex in 1999. • Completed the year ranked # 10 companywide for Daypro in 1998.
-
-
Education
-
Nova Southeastern University
Master of Business Administration - MBA, Business Administration and Management, General -
Nova Southeastern University
Master of Science - MS, Health Services Administration -
University of South Florida
Bachelor of Science - BS, Business Administration and Management, General